Bionano Genomics (BNGO) Registration Filing summary

Company overview and business model

• Provides genome analysis solutions for research and clinical applications, including OGM solutions, diagnostic services, and proprietary software and nucleic acid extraction technologies.

• Operates through subsidiaries offering OGM-based diagnostic testing and platform-agnostic genome analysis software.

• Mission is to transform genome analysis in biology and medicine.

Financial performance and metrics

• Identified as a "smaller reporting company" with market value and revenue below SEC thresholds, allowing for reduced public disclosure requirements.

• Most recent audited financial statements include an explanatory paragraph regarding ability to continue as a going concern.

Use of proceeds and capital allocation

• Will not receive any proceeds from the resale of shares by the selling securityholders; all proceeds go to the selling securityholders.